my TSH moved and I cannot work out whether API source is why
Right, the 503A question again, but with numbers this time.
I have 2 data points over 28 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.
The thing I would flag for anyone new: the effect I am describing showed up at week 89, not week 43. People give up long before the interesting part.
Interested in whether this matches other people's logs or whether I am an outlier.
best — the order this archive was captured in
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
That is net peptide content, not purity. Different number, different meaning.
the shortage list is temporary, it ends and compounding becomes illegal again
503B compounding is different from 503A, different rules, different legality
Sceptical. If this were true we would see it reflected in the data and we do not.
API source questions are on-topic and compounders dodging them is newsworthy
shortage list status is compounding, check the actual list
state board rules differ, say which state
Disagree. What you are describing is consistent with API source, not with what you concluded.
You have restated the marketing copy. What is the actual substance here.
The telehealth + compounding combo cost compounding plus 3% markup. Not cheap but covered by insurance depending on state.
You have restated the marketing copy. What is the actual substance here.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
This is correct. The shortage list does expire and the rules change.
Slight fix: the number was 96.8, not 94.2. Decimal point, but a fairly consequential one.
regulatory claims need a citation to the actual rule, not interpretation
Strongly agree. API source transparency matters.
Disagree. What you are describing is consistent with 503B, not with what you concluded.
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
API transparency is the question that separates good compounders from sketchy ones
API transparency is the question that separates good compounders from sketchy ones
Disagree on that part. 95.1% and 96.2% on the same vial is normal.
Disagree.
Disagree on that part. 99.2% and 99.3% on the same vial is normal.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
API source questions are on-topic and compounders dodging them is newsworthy
- 1Disagree. What you are describing is consistent with 503B, not with what you…7 comments in this branch · started by u/ruben_cabrera
- 2Dead space in the needle hub holds a small but non-trivial volume. On…5 comments in this branch · started by u/lukas_delgado